Tech Company Financing Transactions
Marrow Therapeutics Funding Round
On 11/17/2026, Marrow Therapeutics secured $173 million in financing from OrbiMed, venBio and Affinity Asset Advisors.
Transaction Overview
Company Name
Announced On
11/17/2026
Transaction Type
Venture Equity
Amount
$173,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to advance its bone marrow-targeted genetic medicine programs toward the clinic and expand its manufacturing capabilities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
100 Forge Road 200
Watertown, MA 02472
USA
Watertown, MA 02472
USA
Phone
Undisclosed
Website
Email Address
Overview
Marrow Therapeutics is developing precision medicines to transform the lives of people with sickle cell disease, beta thalassemia and other severe blood diseases. We specifically target the cells affected by these diseases early in their development using validated, antibody-based therapeutics with the potential to achieve a functional cure. Our expert team has deep experience developing tissue-targeted therapeutics and is committed to delivering transformational medicines for patients.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 11/17/2026: Vucar venture capital transaction
Next: 11/17/2026: Bevado venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








